Evidence map›Paper›PMID 36080827›Full record

ArticleSensors (Basel, Switzerland)2022

Smart Diagnostics: Combining Artificial Intelligence and In Vitro Diagnostics.

Michael P McRae, Kritika S Rajsri, Timothy M Alcorn, John T McDevitt

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Limitations of point-of-care testing for low SARS CoV-2 loads: Insights for future pandemics.African journal of primary health care & family medicine · 2025
    Article
  5. Review
  6. Article
  7. A cytomics-on-a-chip platform and diagnostic model stratifies risk for oral lichenoid conditions.Oral surgery, oral medicine, oral pathology and oral radiology · 2024
    Article
  8. A brief review of cytology in dentistry.British dental journal · 2024
    Review
  9. Bias in Laboratory Medicine: The Dark Side of the Moon.Annals of laboratory medicine · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael P McRaeDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, 433 First Ave. Rm 822, New York, NY 10010, USA.ORCID 0000-0002-2126-9442
Kritika S RajsriDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, 433 First Ave. Rm 822, New York, NY 10010, USA.ORCID 0000-0003-2877-3542
Timothy M AlcornLatham BioPharm Group, 6810 Deerpath Rd Suite 405, Elkridge, MD 21075, USA.
John T McDevittDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, 433 First Ave. Rm 822, New York, NY 10010, USA.

Funding

Technology Training and Dissemination CoreU54EB027690 · NIBIB · EMORY UNIVERSITY · PI Wilbur A Lam · 2018 to 2026
$96.1M
Effects of Oral Inflammation on the Levels of Salivary Biomarkers of AMIU01DE017793 · NIDCR · UNIVERSITY OF TEXAS AT AUSTIN · PI MCDEVITT, JOHN T · 2006 to 2012
$13.0M
Oral Dysplasia and Oral Cavity Cancer Risk in Dental and Medical Surveillance Settings Using a Chairside Chip-Based Cytopathology ToolR01DE031319 · NIDCR · NEW YORK UNIVERSITY · PI JOHN T MCDEVITT · 2022 to 2026
$3.7M
Monitoring of Oral Cancer Patients Using Novel Lab-on-a-Chip EnsemblesRC2DE020785 · NIDCR · RICE UNIVERSITY · PI MCDEVITT, JOHN T · 2009 to 2012
$3.5M
Lab-on-a-Chip-Based System for Detection and Monitoring of Oral Cancer in Dental SettingsR44DE025798 · NIDCR · SENSODX II, LLC · PI MCDEVITT, JOHN T, MEHALSO, ROBERT · 2016 to 2018
$1.7M
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cellsR01DE024392 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ANNAPRAGADA, ANANTH V, VIGNESWARAN, NADARAJAH · 2014 to 2017
$1.5M
Cancer Prevention and Research Institute of Texas N/ADelta Dental of Michigan N/ANIBIB NIH HHS U54 EB027690NIDCR NIH HHS R01 DE024392NIDCR NIH HHS R01 DE031319NIDCR NIH HHS R44 DE025798NIDCR NIH HHS RC2 DE020785NIDCR NIH HHS U01 DE017793NIH HHS 1RC2DE020785-01NIH HHS 3 U01 DE017793-02S1NIH HHS 4R44DE 025798-02NIH HHS 5 U01 DE017793-2NIH HHS 5U54EB027690-04NIH HHS R01DE024392NIH HHS R01DE031319-01Renaissance Health Services Corporation N/A
6 · The paper itself

Abstract

We are beginning a new era of

Indexed as

Biosensing TechniquesCOVID-19Artificial IntelligenceCOVID-19 TestingHumansMicrofluidicsPoint-of-Care Systemsartificial intelligenceclinical decision support toolcytologyimmunoassayin vitro diagnosticslab on a chippoint of care

Identifiers

PMID36080827
PMCPMC9459970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.